Work

Periplocin inhibits hepatocellular carcinoma progression and reduces the recruitment of MDSCs through AKT/NF-κB pathway

Year: 2023

Type: article

Source: Life Sciences

DOI: 10.1016/j.lfs.2023.121715

Authors: Jia-Peng Lin, Mao-Hua Huang, Zhi-Ting Sun, Lei Chen, Yu-He Lei, Yu-Qing Huang, Ming Qi, Shu-Ran Fan, Shou-Guo Chen, Chi-Wing Chung, Mei-Ching Chan, Jun-Shan Liu, Min Hu, Min-Feng Chen, Wen-Cai Ye, Yue-Yue Chen, Li-Juan Deng

Institutions: Jinan University, First Affiliated Hospital of Jinan University, Guangzhou University of Chinese Medicine, Zhujiang Hospital, Southern Medical University

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4366975772

FWCI: 3.72

Cites: 27

Cited by: 31

Related to: 10